Virotherapy News and Research

RSS
Virotherapy is treatment using a virus that has been changed in the laboratory to find and destroy cancer cells without harming healthy cells. It is a type of targeted therapy. Also called oncolytic virotherapy, oncolytic virus therapy, and viral therapy.
Themis, Max-Planck-Innovation sign license agreement to develop and commercialize oncolytic virotherapies

Themis, Max-Planck-Innovation sign license agreement to develop and commercialize oncolytic virotherapies

Researchers develop cancer vaccine platform to improve efficacy of oncolytic enveloped viruses

Researchers develop cancer vaccine platform to improve efficacy of oncolytic enveloped viruses

New clinical trial to evaluate virotherapy and immunotherapy combination for ovarian, colorectal cancers

New clinical trial to evaluate virotherapy and immunotherapy combination for ovarian, colorectal cancers

Mayo discovery could enable development of personalized ovarian, brain cancer treatments

Mayo discovery could enable development of personalized ovarian, brain cancer treatments

Pioneering study could be a step closer to finding the most effective way to treat cancer

Pioneering study could be a step closer to finding the most effective way to treat cancer

Researchers reveal promising method for delivering cancer virotherapy

Researchers reveal promising method for delivering cancer virotherapy

Scientists receive critical funding to study treatments for three deadly cancers

Scientists receive critical funding to study treatments for three deadly cancers

Scientists develop potential new therapy for targeting skin cancer metastases in the brain

Scientists develop potential new therapy for targeting skin cancer metastases in the brain

Combination of immunotherapies effective against mouse model of rhabdomyosarcoma

Combination of immunotherapies effective against mouse model of rhabdomyosarcoma

Phase 1 trial shows safety and tolerability of oncolytic HSV-1 for children, young adults with cancer

Phase 1 trial shows safety and tolerability of oncolytic HSV-1 for children, young adults with cancer

IDIBELL scientists develop oncolytic virus capable of redirecting immune system to attack cancer cells

IDIBELL scientists develop oncolytic virus capable of redirecting immune system to attack cancer cells

Oncolytic virotherapy medicine shows positive treatment outcomes in late-stage cancer patients

Oncolytic virotherapy medicine shows positive treatment outcomes in late-stage cancer patients

Study ignores possibility that drugs, chemicals affect sexes differently

Study ignores possibility that drugs, chemicals affect sexes differently

Viralytics enters into clinical trial collaboration agreement with MSD

Viralytics enters into clinical trial collaboration agreement with MSD

Oncolytic virotherapy lends benefits to melanoma patients

Oncolytic virotherapy lends benefits to melanoma patients

UCL research opens up new way to treat neurological disorders

UCL research opens up new way to treat neurological disorders

Transgene welcomes SillaJen’s intention to acquire Jennerex

Transgene welcomes SillaJen’s intention to acquire Jennerex

Viralytics releases financial results for 2013

Viralytics releases financial results for 2013

Recombinant Newcastle disease virus kills all kinds of prostate cancer cells

Recombinant Newcastle disease virus kills all kinds of prostate cancer cells

Natural killer cell response detrimental to glioblastoma virotherapy

Natural killer cell response detrimental to glioblastoma virotherapy